The $1,000 genome has long been considered a milestone—the price at which sequencing can finally go mainstream. Companies such as 23andMe provide inexpensive consumer tests that examine about half a million points of a person’s DNA sequence. But until now investigating all 3 billion base pairs that make up a human’s genome cost $10,000 or more.